Windtree Therapeutics - Warrants (25/03/2026) (WINT+) Q1 2023 Earnings

15MayExpected
Q2 2022
Q3 2022
Q4 2022
Q1 2023
-13
-8.74
-4.47
-0.21

Details

Expected EPS
-0.56
Actual EPS
-4.76
Surprise EPS
-4.2
Surprise Percent
+750%

Description

Windtree Therapeutics - Warrants (25/03/2026) (WINT+) has reported earnings of -4.76 per share for Q1 2023.

0 Comments

Share your thoughts